Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “air”

656 pharma patents match "air" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 656
Index total 30,257
Page 3 / 28

Quick answer

This filtered view shows 656 pharmaceutical patents matching "air" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

656 results for “air” · 30,257 patents in full index Clear search

  1. US 12173314

    Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes

    United States Government as represented by the Department of Veterans Affairs · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  2. US 12161655

    Methods of treating mycobacterial infections using tetracycline compounds

    United States Government as represented by the Department of Veterans Affairs · Granted Dec 10, 2024 · Expires Dec 5, 2044

    granted
  3. US 12162818

    Inhibitors of the n-terminal domain of the androgen receptor

    The United States Government represented by the Department of Veterans Affairs · Granted Dec 10, 2024 · Expires Dec 5, 2044

    granted
  4. US 12150777

    Treatment of depression

    United States Government as represented by the Department of Veterans Affairs · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted
  5. US 12144788

    Visual cycle modulators

    The United States Government as Represented by The Department of Veteran Affairs · Granted Nov 19, 2024 · Expires Nov 14, 2044

    granted
  6. US 12139711

    Antisense oligonucleotides for the treatment of Leber congenital amaurosis

    Stichting Radboud universitair medisch centrum · Granted Nov 12, 2024 · Expires Nov 7, 2044

    granted
  7. US 12122853

    Compositions and methods of inhibiting the binding of plasma IGG autoantibodies to serotonin 2A receptor

    United States Government as represented by the Department of Veterans Affairs · Granted Oct 22, 2024 · Expires Oct 17, 2044

    granted
  8. US 12121526

    Targeting NCCA-ATP channel for organ protection following ischemic episode

    United States Government as represented by the Department of Veterans Affairs · Granted Oct 22, 2024 · Expires Oct 17, 2044

    granted
  9. US 12116416

    Targeting intracellular target-binding determinants with intracellular antibodies

    United States Government as represented by the Department of Veterans Affairs · Granted Oct 15, 2024 · Expires Oct 10, 2044

    granted
  10. US 12110504

    Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes

    United States Government as represented by the Department of Veterans Affairs · Granted Oct 8, 2024 · Expires Oct 3, 2044

    granted
  11. US 12102640

    Use of dopamine and serotonin receptor antagonists for treatment in a subject with retinal degeneration

    United States Government as represented by the Department of Veterans Affairs · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  12. US 12102688

    Immunomodulatory nanofilaments

    Stichting Radboud universitair medisch centrum · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  13. WO 2024188802

    PROCÉDÉS D'ISOLEMENT DE POXVIRUS À PARTIR DE CULTURES DE CELLULES AVIAIRES

    BAVARIAN NORDIC AS [DK] · Granted Sep 19, 2024 · Expires Sep 14, 2044

    granted
  14. WO 2024188801

    UTILISATION DE LIGNÉES CELLULAIRES DE CAILLE POUR PRODUCTION DE POXVIRUS

    BAVARIAN NORDIC AS [DK] · Granted Sep 19, 2024 · Expires Sep 14, 2044

    granted
  15. US 12090145

    Combination therapy for treating or preventing depression or other mood diseases

    United States Government as represented by the Department of Veterans Affairs · Granted Sep 17, 2024 · Expires Sep 12, 2044

    granted
  16. US 12090175

    Compositions and methods for tissue repair with extracellular matrices

    The Regents of the University of California · Granted Sep 17, 2024 · Expires Sep 12, 2044

    granted
  17. US 12060396

    Fused in sarcoma (FUS) nuclear translocation inhibitors for preventing fibrosis

    THE UNITED STATES AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  18. US 12054749

    Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  19. US 12049486

    PAC1 receptor agonists (MAXCAPs) and uses thereof

    The United States Government represented by the Department of Veterans Affairs · Granted Jul 30, 2024 · Expires Jul 25, 2044

    granted
  20. US 12036314

    Compositions and methods for in situ-forming tissue constructs

    United States Government as represented by the Department of Veterans Affairs · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  21. US 12036255

    Bacteriophage compositions and methods for treatment of bacterial infections

    United States Government as represented by the Department of Veterans Affairs · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  22. US 12016884

    Adipose derived stem cell exosomes and uses thereof

    United States Government as represented by the Department of Veterans Affairs · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  23. US 11999720

    Pyrazolylacylpyrazoline compounds and method for treating pain

    United States Government as represented by the Department of Veterans Affairs · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  24. US 11998520

    Methods for decreasing injuries associated with intraoperative hypotension

    United States Government as represented by the Department of Veterans Affairs · Granted Jun 4, 2024 · Expires May 30, 2044

    granted